Tonix Pharmaceuticals Holding (TNXP) Other Working Capital Changes (2020 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Other Working Capital Changes came in at $80000.0 in Q1 2026, up 1700.0% year-on-year from $4444.4 in Q1 2025, and up 128.07% quarter-over-quarter from -$285000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $80000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 1700.0% year-over-year to $80000.0 in Q1 2026; TTM through Mar 2026 was -$218000.0, a 990.0% decrease from a year earlier, with the FY2025 full-year figure at -$303000.0, down 2230.77% from the prior year.
- Other Working Capital Changes climbed to $80000.0 in Q1 2026 per TNXP's latest filing, from -$285000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.2 million in Q2 2022 and bottomed at -$3.6 million in Q3 2022.
- The 5-year median for Other Working Capital Changes is $341000.0 (2024), against an average of -$93117.6.
- Across the five-year window, Other Working Capital Changes slumped 5600.0% in 2025 and surged 1700.0% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$3000.0 in 2022, then soared by 466.67% to $11000.0 in 2023, then tumbled by 145.45% to -$5000.0 in 2024, then slumped by 5600.0% to -$285000.0 in 2025, then jumped by 128.07% to $80000.0 in 2026.
- Per Business Quant, the three latest TNXP Other Working Capital Changes figures stand at $80000.0 (Q1 2026), -$285000.0 (Q4 2025), and -$6000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80,000.00 |
| Mar 31, 2026 | 80,000.00 |
| Mar 31, 2026 | 80,000.00 |
| Dec 31, 2025 | -285,000.00 |
| Dec 31, 2025 | -285,000.00 |
| Dec 31, 2025 | -285,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | -6,000.00 |
| Sep 30, 2024 | -6,000.00 |